Evolus, Inc. posts $-74.41 million annual loss

Evolus, Inc.. [EOLS]  has posted annual loss of $-74.41 million for the year ended Dec 31,2022.

The company based in California(CA)reported a risein revenue to $146.59 milion for the year when compared to $99.67 million in the previous year.

A filing from the company with the Securities and Exchange Commission on Mar 8,2023 showed that its revenue is  down 47.07% year-over-year.

The company reported basic earnings per share of $56065297 and diluted earnings per share of $56065297.

Evolus, Inc.. operates in the Pharmaceutical Preparations sector.